| HOME >> MEDICINE >> TECHNOLOGY |
Administration Route II-3
Market Fundamentals: A Current Review II-3
Respiratory Disorders: A Large & Mature Therapeutic Category II-4
Widely Prescribed Inhalation Drugs for Asthma & COPD II-5
Inhaler Devices: An Integral Part of Pulmonary Drug Delivery II-5
Pulmonary Delivery of Systemic Drugs: A Future Growth Area II-5
Delivering Macromolecules Through the Lungs: A Current Focus
Area II-6
Innovations in Inhalation Aerosols II-7
Current Drugs in Pipeline: A Review II-8
Inhaled Drugs in Pipeline as of the Year 2008 & 2009 II-8
Noteworthy Trends & Issues II-11
Nanotechnology Makes its Presence Felt in Inhaled Drugs II-11
Innovation in Inhaler Devices: A Key Differentiating Factor II-12
Innovation is the Name of the Game in the Nebulizer Segment II-12
Nebulizers for Pediatric Care: Need of the Hour II-13
CFC Propellants Give Way to HFA II-14
Chinks in MDI's Armor Work in Favor of DPI Market II-14
Potential Challenges for DPI Market II-14
Combination Therapy: An Effective Strategy in Optimum
Disease Management II-15
2. PRODUCT OVERVIEW II-16
Definition of Pulmonary Drug Delivery System II-16
Benefits of Pulmonary Drug Delivery Systems II-16
Therapeu
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |